Tim Chiu
Research Subjects
Tim Chiu has a total of 202 co-authors. Here are the top co-authors by number of shared publications:
- Amira Klip
The Hospital for Sick Children
2 shared publications Abraham Brass
17432 Alsin, Fredrik, 17460 Altamentova, Svetlana
1 shared publication- Adel M. Nour
Department of Molecular Microbiology and Immunology, Brown University, Providence, Rhode Island, United States of America
1 shared publication - Adrienne Grzenda
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles
1 shared publication - Ahmed Bettaieb
Department of Nutrition, University of Tennessee Knoxville, Knoxville, TN 37996-0840, USA
1 shared publication Aimee H. Marceau
17432 Alsin, Fredrik, 17460 Altamentova, Svetlana
1 shared publication
Latest Publications
- Open Access
- 26 June 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (27)
The Rho guanine dissociation inhibitor α inhibits skeletal muscle Rac1 activity and insulin action
The molecular events governing skeletal muscle glucose uptake have pharmacological potential for managing insulin resistance in conditions such as obesity, diabetes, and cancer. With no current pharmacological treatments to target skeletal muscle insulin sensitivity, there is an unmet need to identify the molecular mechanisms that control insulin sensitivity in skeletal muscle. Here, the Rho guanine dissociation inhibitor α (RhoGDIα) is identified as a point of control in the regulation of insulin sensitivity. In skeletal muscle cells, RhoGDIα interacted with, and thereby inhibited, the Rho GTPase Rac1. In response to insulin, RhoGDIα was phosphorylated at S101 and Rac1 dissociated from RhoGDIα to facilitate skeletal muscle GLUT4 translocation. Accordingly, siRNA-mediated RhoGDIα depletion increased Rac1 activity and elevated GLUT4 translocation. Consistent with RhoGDIα’s inhibitory effect, rAAV-mediated RhoGDIα overexpression in mouse muscle decreased insulin-stimulated glucose uptake and was detrimental to whole-body glucose tolerance. Aligning with RhoGDIα’s negative role in insulin sensitivity, RhoGDIα protein content was elevated in skeletal muscle from insulin-resistant patients with type 2 diabetes. These data identify RhoGDIα as a clinically relevant controller of skeletal muscle insulin sensitivity and whole-body glucose homeostasis, mechanistically by modulating Rac1 activity.
- 26 June 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (27)
Open AccessThe Rho guanine dissociation inhibitor α inhibits skeletal muscle Rac1 activity and insulin action
The molecular events governing skeletal muscle glucose uptake have pharmacological potential for managing insulin resistance in conditions such as obesity, diabetes, and cancer. With no current pharmacological treatments to target skeletal muscle insulin sensitivity, there is an unmet need to identify the molecular mechanisms that control insulin sensitivity in skeletal muscle. Here, the Rho guanine dissociation inhibitor α (RhoGDIα) is identified as a point of control in the regulation of insulin sensitivity. In skeletal muscle cells, RhoGDIα interacted with, and thereby inhibited, the Rho GTPase Rac1. In response to insulin, RhoGDIα was phosphorylated at S101 and Rac1 dissociated from RhoGDIα to facilitate skeletal muscle GLUT4 translocation. Accordingly, siRNA-mediated RhoGDIα depletion increased Rac1 activity and elevated GLUT4 translocation. Consistent with RhoGDIα’s inhibitory effect, rAAV-mediated RhoGDIα overexpression in mouse muscle decreased insulin-stimulated glucose uptake and was detrimental to whole-body glucose tolerance. Aligning with RhoGDIα’s negative role in insulin sensitivity, RhoGDIα protein content was elevated in skeletal muscle from insulin-resistant patients with type 2 diabetes. These data identify RhoGDIα as a clinically relevant controller of skeletal muscle insulin sensitivity and whole-body glucose homeostasis, mechanistically by modulating Rac1 activity.
- Open Access
- 1 June 2013
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 288 (24)
Author Index
- 1 June 2013
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 288 (24)
Open AccessAuthor Index